Literature DB >> 17566607

Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.

Shinji Hadano1, Ryota Kunita, Asako Otomo, Kyoko Suzuki-Utsunomiya, Joh-E Ikeda.   

Abstract

ALS2 is a causative gene for a juvenile autosomal recessive form of motor neuron diseases (MNDs), including amyotrophic lateral sclerosis 2 (ALS2), juvenile primary lateral sclerosis, and infantile-onset ascending hereditary spastic paralysis. These disorders are characterized by ascending degeneration of the upper motor neurons with or without lower motor neuron involvement. Thus far, a total of 12 independent ALS2 mutations, which include a small deletion, non-sense mutation, or missense mutation spreading widely across the entire coding sequence, are reported. They are predicted to result in either premature termination of translation or substitution of an evolutionarily conserved amino acid. Thus, a loss of functions in the ALS2-coded protein accounts for motor dysfunction and/or degeneration in the ALS2-linked MNDs. The ALS2 gene encodes a novel 184kDa protein of 1657 amino acids, ALS2 or alsin, comprising three predicted guanine nucleotide exchange factor (GEF) domains: the N-terminal RCC1-like domain, the central Dbl homology and pleckstrin homology (DH/PH) domains, and the C-terminal vacuolar protein sorting 9 (VPS9) domain. In addition, eight consecutive membrane occupation and recognition nexus (MORN) motifs are noted in the region between DH/PH and VPS9 domains. ALS2 activates Rab5 small GTPase and involves in endosome/membrane trafficking and fusions in the cells, and also promotes neurite outgrowth in neuronal cultures. Further, a neuroprotective role for ALS2 against cytotoxicity; i.e., the mutant Cu/Zn-superoxide dismutase 1 (SOD1)-mediated toxicity, oxidative stress, and excitotoxicity, has recently been implied. This review outlines current understandings of the molecular and cellular functions of ALS2 and its related proteins on safeguarding the integrity of motor neurons, and sheds light on the molecular pathogenesis of MNDs as well as other conditions of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566607     DOI: 10.1016/j.neuint.2007.04.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  28 in total

1.  Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity.

Authors:  Qiang Li; Netanya Y Spencer; Nicholas J Pantazis; John F Engelhardt
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

Review 2.  Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors:  Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 3.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

Review 4.  DNA repair deficiency in neurodegeneration.

Authors:  Dennis Kjølhede Jeppesen; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Prog Neurobiol       Date:  2011-04-30       Impact factor: 11.685

5.  UBAP1 mutations cause juvenile-onset hereditary spastic paraplegias (SPG80) and impair UBAP1 targeting to endosomes.

Authors:  Haitian Nan; Yuta Ichinose; Masaki Tanaka; Kishin Koh; Hiroyuki Ishiura; Jun Mitsui; Heisuke Mizukami; Masafumi Morimoto; Shun Hamada; Toshihisa Ohtsuka; Shoji Tsuji; Yoshihisa Takiyama
Journal:  J Hum Genet       Date:  2019-09-12       Impact factor: 3.172

6.  Maternal uniparental heterodisomy with partial isodisomy of a chromosome 2 carrying a splice acceptor site mutation (IVS9-2A>T) in ALS2 causes infantile-onset ascending spastic paralysis (IAHSP).

Authors:  Thilo Herzfeld; Nicole Wolf; Pia Winter; Holger Hackstein; Daniel Vater; Ulrich Müller
Journal:  Neurogenetics       Date:  2008-09-23       Impact factor: 2.660

7.  Localized regulation of axonal RanGTPase controls retrograde injury signaling in peripheral nerve.

Authors:  Dmitry Yudin; Shlomit Hanz; Soonmoon Yoo; Elena Iavnilovitch; Dianna Willis; Tal Gradus; Deepika Vuppalanchi; Yael Segal-Ruder; Keren Ben-Yaakov; Miki Hieda; Yoshihiro Yoneda; Jeffery L Twiss; Mike Fainzilber
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

8.  Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking.

Authors:  Shinji Hadano; Asako Otomo; Ryota Kunita; Kyoko Suzuki-Utsunomiya; Akira Akatsuka; Masato Koike; Masashi Aoki; Yasuo Uchiyama; Yasuto Itoyama; Joh-E Ikeda
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  A Toxoplasma MORN1 null mutant undergoes repeated divisions but is defective in basal assembly, apicoplast division and cytokinesis.

Authors:  Alexander Lorestani; Lilach Sheiner; Kevin Yang; Seth D Robertson; Nivedita Sahoo; Carrie F Brooks; David J P Ferguson; Boris Striepen; Marc-Jan Gubbels
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

10.  Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).

Authors:  Laura E Cox; Laura Ferraiuolo; Emily F Goodall; Paul R Heath; Adrian Higginbottom; Heather Mortiboys; Hannah C Hollinger; Judith A Hartley; Alice Brockington; Christine E Burness; Karen E Morrison; Stephen B Wharton; Andrew J Grierson; Paul G Ince; Janine Kirby; Pamela J Shaw
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.